Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
02/2010
02/17/2010EP2152888A2 Enhancement of seed oil / amino acid content by combinations of pyruvate kinase subunits
02/17/2010EP2152882A2 Cells expressing chimeric proteins and assays using such cells
02/17/2010EP2152872A2 Method for manufacturing a recombinant polyclonal protein
02/17/2010EP2152861A2 Inducible mutagenesis of target genes
02/17/2010EP2152860A2 Peptide linked cell matrix materials for stem cells and methods of using the same
02/17/2010EP2152858A2 Hematopoietic cells that express mosc-1
02/17/2010EP2152857A1 Induction of dendritic cell development with macrophage-colony stimulating factor (m-csf)
02/17/2010EP2152856A1 Improved feed media
02/17/2010EP2152855A1 Recombinant protein production in avian ebx® cells
02/17/2010EP2152851A2 Improved bioreactor surfaces
02/17/2010EP2152754A2 Monoclonal antibodies against claudin-18 for treatment of cancer
02/17/2010EP2152739A2 Mutants of interleukin-1 receptor antagonist and uses thereof
02/17/2010EP2152736A1 Complement factor h-derived short consensus repeat-antibody constructs
02/17/2010EP1492410B1 Triglyceride fat
02/17/2010EP1490013B1 Methods for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising hydroxyurea
02/17/2010EP1404816B1 Human hepatoma cell lines, methods for obtaining same and uses thereof
02/17/2010EP1263954B1 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis
02/17/2010EP1133560B1 Human parathyroid hormone modifications, preparation and use
02/17/2010EP1071700B1 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
02/17/2010CN101652472A Enhancement of hybridoma fusion efficiencies through cell synchronization
02/17/2010CN101652470A Use of bone marrow cells for long term culture of pancreatic islet cells
02/17/2010CN101652469A Method for identifying and manipulating cells
02/17/2010CN101649307A Method and compositions for improved polynucleotide synthesis
02/17/2010CN100590198C Method and compositions for improved polynucleotide synthesis
02/17/2010CN100590195C Genes from propionibacterium freudenreichii encoding enzymes involved in vitamin B12 biosynthesis
02/17/2010CN100590131C Methods and compounds for the targeting of protein to exosomes
02/17/2010CN100589845C Anti-neovasculature preparations for cancer
02/16/2010US7663030 Inbred corn line G07-NPFA7183
02/16/2010US7663027 Nucleotide sequences and corresponding polypeptides conferring modulated plant size and biomass in plants
02/16/2010US7663020 Generation of plants with altered oil content
02/16/2010US7663018 Animal model involving transgenic manipulation of amyloid precursor protein; useful for testing potential therapeutic agents for the treatment of neurodegenerative disorders, in particular Alzheimer's disease; drug screening
02/16/2010US7663017 animal models having disrupted genes, used to test the immunogenicity of human vaccine candidates; drug screening
02/16/2010US7662948 Antisense oligonucleotides against VR1
02/16/2010US7662947 Arabidopsis-stomatal-specific promoter and a genetic construct containing the promoter for expression of nucleic acids in plants
02/16/2010US7662945 Expression vector comprising nucleotide sequences coding C-terminal 28kDa endostatin-spanning proteolytic fragment for use in prevention and treatment of vision defcets associated with cell proliferative disorders
02/16/2010US7662932 Endothelial growth factor; isolated polypeptide; stimulate cell proliferation, neovascularization, vascular system permeability
02/16/2010US7662928 Anti-FcRn antibodies for treatment of auto/allo immune conditions
02/16/2010US7662768 Transdifferentiation of pancreatic acinar cells
02/16/2010US7662629 Cationic peptide scaffold conjugated to a nuclear targeting peptide through a specified hydrolysis resistant chemical linkage; use in transfection i.e. nonviral gene transfer
02/16/2010US7662626 Cells and methods for estimation of effects on neurological dysfunction
02/16/2010US7662625 Using antibody specific to cell surface glycoprotein (5T4) for use as tool to determine differentiation status of cell populations
02/16/2010US7662623 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site
02/16/2010US7662621 a part of the interior gene is deleted, and the transgene is inserted into the gap created by the deletion; capable of expressing a desired protein in target cells.
02/16/2010US7662620 Stem cell-derived neuron survival factor polypeptides (SDNSF) for use in prevention and treatment of cell proliferative, neurodegenerative and cardiovascular disorders
02/16/2010US7662608 Transgenic cell line modified to procontinuously produce budding particle for use as model in diagnostic screening and testing; drug monitoring; antitumor agents; viricides
02/16/2010US7662603 serine hydroxymethyltransferase as novel target for herbicides
02/16/2010US7662591 Nucleic acid sequences having gene transcription regulatory qualities
02/16/2010US7662586 host cells; tumor antigens; for treatment, prevention of cancer
02/16/2010US7662585 ErbB4 receptor-specific neuregulin related ligands and uses therefor
02/16/2010US7662583 Nutrient medium free of exogenous supply of UDP-glucose; quercetin glycosylation
02/16/2010US7662548 Method of screening for modulators of HIV infection
02/16/2010US7662410 with target membrane or other hydrophobic proteins (G protein coupled receptor protein) or membrane fragments to form soluble nanoscale particles which preserve their native structure and function; allows manipulation of incorporated proteins in solution or on solid supports
02/16/2010US7662399 BASB054 polypeptides
02/16/2010US7662395 Recombinant virus encoding an antigen of a disease state; second recombinant virus encoding an immunostimulatory molecule with an exogenous immunostimulatory molecule, chemotherapeutic drug, antibiotic, antiviral drug or antifungal drug.
02/16/2010US7662394 Nucleic acids encoding chimeric Flavivirus immunogens comprising the Japanese encephalitis virus (JEV) PRM signal sequence
02/16/2010US7662392 Stromal-Derived Factor-1 (SDF), G-CSF (granulocyte-colony stimulating factor), stimulating vasculogenesis; improves cardiac function
02/16/2010US7662391 Polynucleotide sequence for Chalmydia pneumonia; therapy, prevention of Chlamydia infections ; vaccines
02/16/2010US7662385 Agent for inhibiting proliferation of neural stem cells
02/16/2010US7662380 ZAQ ligand-1 antibodies and uses thereof
02/16/2010CA2614785C Regulation of antigen presentation
02/16/2010CA2223701C Fgf9 as a specific ligand for fgfr3
02/11/2010WO2010017562A2 Induced pluripotent stem cells
02/11/2010WO2010017551A2 Method for mir-125a in promoting hematopoietic stem cell self renewal and expansion
02/11/2010WO2010017509A1 Modulation of transthyretin expression for the treatment of cns related disorders
02/11/2010WO2010017496A1 Biodegradable nerve scaffold conduit for the treatment of nerve injuries
02/11/2010WO2010017338A1 METHOD FOR CONTROLLING pH, OSMOLALITY AND DISSOLVED CARBON DIOXIDE LEVELS IN A MAMMALIAN CELL CULTURE PROCESS TO ENHANCE CELL VIABILITY AND BIOLOGIC PRODUCT YIELD
02/11/2010WO2010017337A1 System and method for controlling a mammalian cell culture process
02/11/2010WO2010017220A1 Methods for expanding regulatory t-cells
02/11/2010WO2010017216A2 Mesenchymal stromal cell populations and methods of isolating and using same
02/11/2010WO2010016800A1 Microfluidic continuous flow device
02/11/2010WO2010016765A1 Prf in cell and tissue culture
02/11/2010WO2010016621A1 Rna polymerase mutant with improved functions
02/11/2010WO2010016469A1 Technique for regulating regeneration of tissue or faulty or abnormal part in organ using nell-1
02/11/2010WO2010016253A1 Method for selecting secondary neurosphere derived from differentiated cell-derived pluripotent stem cell, clone selected by the method and use of the clone
02/11/2010WO2010015831A2 Process for cultivating cells
02/11/2010WO2010015722A1 Cells producing glycoproteins having altered glycosylation patterns and methods and use thereof
02/11/2010WO2010015714A1 Mutant alpha-synuclein, and methods using same
02/11/2010WO2010015619A2 Cell-based method and means for rebuilding bone
02/11/2010WO2010015087A1 Method of inducing stem cell differentiation
02/11/2010WO2009136298A3 Compositions and methods for inhibiting shiga toxin and shiga-like toxin
02/11/2010WO2009120741A3 Inhibition of trim62 activity reduces cancer cell proliferation
02/11/2010WO2009043159A8 Neural tumor stem cells and methods of use thereof
02/11/2010US20100037357 Polynucleotides Encoding Phenylpropanoid and Falvonoid Biosynthetic Pathway Enzymes in Coffee
02/11/2010US20100037355 Sequence-determined dna fragments and corresponding polypeptides encoded thereby
02/11/2010US20100037354 Transgenic plants containing altered levels of steroid compounds
02/11/2010US20100037352 Sequence-determined dna fragments and corresponding polypeptides encoded thereby
02/11/2010US20100037350 Plants with increased yield
02/11/2010US20100037349 Variants of nrr activate plant disease resistance
02/11/2010US20100037348 Nucleotide sequences coding insecticidal protein for use in transformation and generation of plants resistant to lepidopteran or coleopteran pest; pesticides; biological pest control
02/11/2010US20100037347 Seed-Preferred Regulatory Elements
02/11/2010US20100037346 Promoter, promoter control elements, and combinations, and uses thereof
02/11/2010US20100037344 Promoter, Promoter Control Elements, and Combinations, and Uses Thereof
02/11/2010US20100037343 Clubroot resistant brassica oleracea plants
02/11/2010US20100037341 Soybean variety d5123854
02/11/2010US20100037340 Soybean variety d5231451
02/11/2010US20100037330 Efficient Somatic Cell Nuclear Transfer In Fish
02/11/2010US20100037329 Development of sensitive fret sensors and methods of using the same
02/11/2010US20100037328 Cd20-negatively converted b cell malignant lymphocyte cell line and utilization of the same
02/11/2010US20100036492 Osteochondral implants, arthroplasty methods, devices, and systems
02/11/2010US20100036100 T cell proteins and nucleotides encoding the same